Research ExplorerPublicationsCOMPARISON OF 1470NM DIODE LASER VS C02-LASERLASER FOR TONSI...

COMPARISON OF 1470NM DIODE LASER VS C02-LASERLASER FOR TONSILLOTOMY AND A CLINICAL FEASABILITY TRIAL ON THE USE OF 1940NM IN ENT

Standard

COMPARISON OF 1470NM DIODE LASER VS C02-LASERLASER FOR TONSILLOTOMY AND A CLINICAL FEASABILITY TRIAL ON THE USE OF 1940NM IN ENT. / Sroka, Ronald; Pongratz, Thomas; Havel, Miriam; Englert, Elsa; Kremser, Thomas; Betz, Christian S.; Leunig, Andreas.

PHOTONIC THERAPEUTICS AND DIAGNOSTICS IX. ed. / N Kollias; B Choi; H Zeng; HW Kang; BE Knudsen; BJF Wong; JF Ilgner; MJ Suter; S Lam; M Brenner; KW Gregory; GJ Tearney; L Marcu; H Hirschberg; SJ Madsen; A MahadevanJansen; ED Jansen; A Mandelis. Vol. 8565 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA : SPIE-INT SOC OPTICAL ENGINEERING, 2013. (Proceedings of SPIE).

Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

Harvard

Sroka, R, Pongratz, T, Havel, M, Englert, E, Kremser, T, Betz, CS & Leunig, A 2013, COMPARISON OF 1470NM DIODE LASER VS C02-LASERLASER FOR TONSILLOTOMY AND A CLINICAL FEASABILITY TRIAL ON THE USE OF 1940NM IN ENT. in N Kollias, B Choi, H Zeng, HW Kang, BE Knudsen, BJF Wong, JF Ilgner, MJ Suter, S Lam, M Brenner, KW Gregory, GJ Tearney, L Marcu, H Hirschberg, SJ Madsen, A MahadevanJansen, ED Jansen & A Mandelis (eds), PHOTONIC THERAPEUTICS AND DIAGNOSTICS IX. vol. 8565, Proceedings of SPIE, SPIE-INT SOC OPTICAL ENGINEERING, 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA. https://doi.org/10.1117/12.2007497

APA

Sroka, R., Pongratz, T., Havel, M., Englert, E., Kremser, T., Betz, C. S., & Leunig, A. (2013). COMPARISON OF 1470NM DIODE LASER VS C02-LASERLASER FOR TONSILLOTOMY AND A CLINICAL FEASABILITY TRIAL ON THE USE OF 1940NM IN ENT. In N. Kollias, B. Choi, H. Zeng, HW. Kang, BE. Knudsen, BJF. Wong, JF. Ilgner, MJ. Suter, S. Lam, M. Brenner, KW. Gregory, GJ. Tearney, L. Marcu, H. Hirschberg, SJ. Madsen, A. MahadevanJansen, ED. Jansen, & A. Mandelis (Eds.), PHOTONIC THERAPEUTICS AND DIAGNOSTICS IX (Vol. 8565). (Proceedings of SPIE). SPIE-INT SOC OPTICAL ENGINEERING. https://doi.org/10.1117/12.2007497

Vancouver

Sroka R, Pongratz T, Havel M, Englert E, Kremser T, Betz CS et al. COMPARISON OF 1470NM DIODE LASER VS C02-LASERLASER FOR TONSILLOTOMY AND A CLINICAL FEASABILITY TRIAL ON THE USE OF 1940NM IN ENT. In Kollias N, Choi B, Zeng H, Kang HW, Knudsen BE, Wong BJF, Ilgner JF, Suter MJ, Lam S, Brenner M, Gregory KW, Tearney GJ, Marcu L, Hirschberg H, Madsen SJ, MahadevanJansen A, Jansen ED, Mandelis A, editors, PHOTONIC THERAPEUTICS AND DIAGNOSTICS IX. Vol. 8565. 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA: SPIE-INT SOC OPTICAL ENGINEERING. 2013. (Proceedings of SPIE). https://doi.org/10.1117/12.2007497

Bibtex

@inbook{b9a31fd58eee4b2b9bf1203cbcb65a07,
title = "COMPARISON OF 1470NM DIODE LASER VS C02-LASERLASER FOR TONSILLOTOMY AND A CLINICAL FEASABILITY TRIAL ON THE USE OF 1940NM IN ENT",
abstract = "Introduction: The need for reduction of post-tonsillectomy hemorrhage has led to promotion of tonsillotomy techniques for tonsil tissue reduction in obstructive tonsillar hypertrophy. A first study compares ablative tissue effects using 1470nm diode laser and CO2-laser for tonsillotomy in an intraindividual design. A number of different laser systems have been used for volume reduction of hyperplastic nasal turbinates. The aim of a 2nd clinical feasibility study was to show the coagulative and tissue reducing effects using a novel Tm: fiber laser system emitting at lambda = 1940 nm Patients and methods: First 21 children aged 3 -13 years (mean age 6.3 years) underwent laser tonsillotomy for obstructive tonsillar hypertrophy in this double blind, prospective, randomized, clinical feasibility trial. In each case, tonsillotomy was performed using fibre guided 1470nm diode laser (contact mode, 15 W power) on the one side and CO2-laser (12 W power) on the other side. An independent physician documented clinical presentation and patients' symptoms preoperatively and on day 1, 3, 7, 14 and 21 postoperatively using standardized questionnaire including VAS (was ist das) for each side separately. The 2nd clinical feasibility trial included 11 patients suffering from hyperplastic inferior nasal turbinates, who were therapy-refractory to conservative medical treatment. The obstructive nasal cavity was treated using the 1940 nm Tm: fiber laser at ",
keywords = "laser, tonsillotomy, turbinate hyperplasia",
author = "Ronald Sroka and Thomas Pongratz and Miriam Havel and Elsa Englert and Thomas Kremser and Betz, {Christian S.} and Andreas Leunig",
note = "Conference on Photonic Therapeutics and Diagnostics IX, San Francisco, CA, FEB 02-07, 2013",
year = "2013",
doi = "10.1117/12.2007497",
language = "English",
isbn = "978-0-8194-9334-7",
volume = "8565",
series = "Proceedings of SPIE",
publisher = "SPIE-INT SOC OPTICAL ENGINEERING",
editor = "N Kollias and B Choi and H Zeng and HW Kang and BE Knudsen and BJF Wong and JF Ilgner and MJ Suter and S Lam and M Brenner and KW Gregory and GJ Tearney and L Marcu and H Hirschberg and SJ Madsen and A MahadevanJansen and ED Jansen and A Mandelis",
booktitle = "PHOTONIC THERAPEUTICS AND DIAGNOSTICS IX",

}

RIS

TY - CHAP

T1 - COMPARISON OF 1470NM DIODE LASER VS C02-LASERLASER FOR TONSILLOTOMY AND A CLINICAL FEASABILITY TRIAL ON THE USE OF 1940NM IN ENT

AU - Sroka, Ronald

AU - Pongratz, Thomas

AU - Havel, Miriam

AU - Englert, Elsa

AU - Kremser, Thomas

AU - Betz, Christian S.

AU - Leunig, Andreas

N1 - Conference on Photonic Therapeutics and Diagnostics IX, San Francisco, CA, FEB 02-07, 2013

PY - 2013

Y1 - 2013

N2 - Introduction: The need for reduction of post-tonsillectomy hemorrhage has led to promotion of tonsillotomy techniques for tonsil tissue reduction in obstructive tonsillar hypertrophy. A first study compares ablative tissue effects using 1470nm diode laser and CO2-laser for tonsillotomy in an intraindividual design. A number of different laser systems have been used for volume reduction of hyperplastic nasal turbinates. The aim of a 2nd clinical feasibility study was to show the coagulative and tissue reducing effects using a novel Tm: fiber laser system emitting at lambda = 1940 nm Patients and methods: First 21 children aged 3 -13 years (mean age 6.3 years) underwent laser tonsillotomy for obstructive tonsillar hypertrophy in this double blind, prospective, randomized, clinical feasibility trial. In each case, tonsillotomy was performed using fibre guided 1470nm diode laser (contact mode, 15 W power) on the one side and CO2-laser (12 W power) on the other side. An independent physician documented clinical presentation and patients' symptoms preoperatively and on day 1, 3, 7, 14 and 21 postoperatively using standardized questionnaire including VAS (was ist das) for each side separately. The 2nd clinical feasibility trial included 11 patients suffering from hyperplastic inferior nasal turbinates, who were therapy-refractory to conservative medical treatment. The obstructive nasal cavity was treated using the 1940 nm Tm: fiber laser at

AB - Introduction: The need for reduction of post-tonsillectomy hemorrhage has led to promotion of tonsillotomy techniques for tonsil tissue reduction in obstructive tonsillar hypertrophy. A first study compares ablative tissue effects using 1470nm diode laser and CO2-laser for tonsillotomy in an intraindividual design. A number of different laser systems have been used for volume reduction of hyperplastic nasal turbinates. The aim of a 2nd clinical feasibility study was to show the coagulative and tissue reducing effects using a novel Tm: fiber laser system emitting at lambda = 1940 nm Patients and methods: First 21 children aged 3 -13 years (mean age 6.3 years) underwent laser tonsillotomy for obstructive tonsillar hypertrophy in this double blind, prospective, randomized, clinical feasibility trial. In each case, tonsillotomy was performed using fibre guided 1470nm diode laser (contact mode, 15 W power) on the one side and CO2-laser (12 W power) on the other side. An independent physician documented clinical presentation and patients' symptoms preoperatively and on day 1, 3, 7, 14 and 21 postoperatively using standardized questionnaire including VAS (was ist das) for each side separately. The 2nd clinical feasibility trial included 11 patients suffering from hyperplastic inferior nasal turbinates, who were therapy-refractory to conservative medical treatment. The obstructive nasal cavity was treated using the 1940 nm Tm: fiber laser at

KW - laser

KW - tonsillotomy

KW - turbinate hyperplasia

U2 - 10.1117/12.2007497

DO - 10.1117/12.2007497

M3 - SCORING: Contribution to collected editions/anthologies

SN - 978-0-8194-9334-7

VL - 8565

T3 - Proceedings of SPIE

BT - PHOTONIC THERAPEUTICS AND DIAGNOSTICS IX

A2 - Kollias, N

A2 - Choi, B

A2 - Zeng, H

A2 - Kang, HW

A2 - Knudsen, BE

A2 - Wong, BJF

A2 - Ilgner, JF

A2 - Suter, MJ

A2 - Lam, S

A2 - Brenner, M

A2 - Gregory, KW

A2 - Tearney, GJ

A2 - Marcu, L

A2 - Hirschberg, H

A2 - Madsen, SJ

A2 - MahadevanJansen, A

A2 - Jansen, ED

A2 - Mandelis, A

PB - SPIE-INT SOC OPTICAL ENGINEERING

CY - 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA

ER -